Stock News

Glenview Capital Management Has Raised Nike (NKE) Stake; Caisse De Depot Et Placement Du Quebec Increased Quest Diagnostics (DGX) Position By $2.84 Million

Caisse De Depot Et Placement Du Quebec increased Quest Diagnostics Inc (DGX) stake by 105.96% reported in 2017Q3 SEC filing. Caisse De Depot Et Placement Du Quebec acquired 30,200 shares as Quest Diagnostics Inc (DGX)’s stock rose 10.72%. The Caisse De Depot Et Placement Du Quebec holds 58,700 shares with $5.52M value, up from 28,500 last quarter. Quest Diagnostics Inc now has $14.11B valuation. The stock increased 0.47% or $0.48 during the last trading session, reaching $103.54. About 451,266 shares traded. Quest Diagnostics Incorporated (NYSE:DGX) has risen 39.04% since January 22, 2017 and is uptrending. It has outperformed by 22.34% the S&P500.

Glenview Capital Management Llc increased Nike Inc (NKE) stake by 163.79% reported in 2017Q3 SEC filing. Glenview Capital Management Llc acquired 1.30M shares as Nike Inc (NKE)’s stock declined 8.78%. The Glenview Capital Management Llc holds 2.09 million shares with $108.50M value, up from 793,319 last quarter. Nike Inc now has $107.96 billion valuation. The stock decreased 1.27% or $0.85 during the last trading session, reaching $66.36. About 5.97 million shares traded. NIKE, Inc. (NYSE:NKE) has declined 9.24% since January 22, 2017 and is downtrending. It has underperformed by 25.94% the S&P500.

Caisse De Depot Et Placement Du Quebec decreased Cooper Cos Inc/The (NYSE:COO) stake by 62,308 shares to 93,658 valued at $22.30M in 2017Q3. It also reduced 3M Co (NYSE:MMM) stake by 35,600 shares and now owns 1.76M shares. Jd.Com Inc (NASDAQ:JD) was reduced too.

Among 21 analysts covering Quest Diagnostics (NYSE:DGX), 7 have Buy rating, 2 Sell and 12 Hold. Therefore 33% are positive. Quest Diagnostics had 58 analyst reports since August 4, 2015 according to SRatingsIntel. Citigroup maintained the shares of DGX in report on Friday, October 20 with “Neutral” rating. The firm earned “Hold” rating on Friday, October 13 by SunTrust. The company was maintained on Friday, November 13 by Canaccord Genuity. Mizuho upgraded Quest Diagnostics Incorporated (NYSE:DGX) rating on Tuesday, January 3. Mizuho has “Buy” rating and $103 target. The company was upgraded on Monday, December 12 by Goldman Sachs. The rating was upgraded by Bank of America to “Buy” on Tuesday, July 25. The company was maintained on Thursday, October 19 by Jefferies. The company was maintained on Sunday, June 11 by Canaccord Genuity. As per Monday, September 25, the company rating was downgraded by Raymond James. Mizuho downgraded the stock to “Neutral” rating in Wednesday, August 31 report.

Investors sentiment decreased to 0.98 in 2017 Q3. Its down 0.01, from 0.99 in 2017Q2. It worsened, as 51 investors sold DGX shares while 184 reduced holdings. 57 funds opened positions while 173 raised stakes. 116.90 million shares or 2.64% more from 113.89 million shares in 2017Q2 were reported. Hutchin Hill Cap Limited Partnership invested in 24,000 shares. Benjamin F Edwards Incorporated reported 410 shares. 1,058 were accumulated by Amica Retiree Med Tru. Moreover, Lsv Asset Mngmt has 0.22% invested in Quest Diagnostics Incorporated (NYSE:DGX). Spark Invest Mgmt Ltd Liability invested in 0.02% or 3,000 shares. Huntington Natl Bank accumulated 0.03% or 18,651 shares. Bowling Portfolio Management Limited Co has invested 0.42% in Quest Diagnostics Incorporated (NYSE:DGX). Moreover, M&R Cap Management has 0.02% invested in Quest Diagnostics Incorporated (NYSE:DGX). Ltd Liability Company has invested 0.05% in Quest Diagnostics Incorporated (NYSE:DGX). Hbk Investments LP holds 5,000 shares. Price T Rowe Associates Md holds 248,462 shares or 0% of its portfolio. 1.19M are held by Investec Asset Limited. Chevy Chase Trust Holdings has invested 0.05% in Quest Diagnostics Incorporated (NYSE:DGX). Lombard Odier Asset Mgmt (Switzerland) Sa reported 0.38% in Quest Diagnostics Incorporated (NYSE:DGX). Manchester Cap Limited Liability Corporation owns 250 shares or 0% of their US portfolio.

Since August 4, 2017, it had 0 insider buys, and 6 insider sales for $17.85 million activity. On Tuesday, September 5 STANZIONE DANIEL sold $410,762 worth of Quest Diagnostics Incorporated (NYSE:DGX) or 3,803 shares. Davis J. E. sold $6.30 million worth of Quest Diagnostics Incorporated (NYSE:DGX) on Tuesday, January 2. 2,525 shares valued at $272,768 were sold by RUSCKOWSKI STEPHEN H on Tuesday, September 5. The insider LEIDEN JEFFREY M sold 296 shares worth $31,571.

Among 44 analysts covering Nike Inc. (NYSE:NKE), 24 have Buy rating, 2 Sell and 18 Hold. Therefore 55% are positive. Nike Inc. had 218 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus with “Buy” on Tuesday, December 15. The stock of NIKE, Inc. (NYSE:NKE) earned “Buy” rating by Macquarie Research on Thursday, January 11. The firm has “Hold” rating by Piper Jaffray given on Friday, July 21. The rating was maintained by Telsey Advisory Group with “Outperform” on Monday, December 18. As per Wednesday, September 28, the company rating was maintained by Citigroup. The firm earned “Neutral” rating on Thursday, October 19 by Goldman Sachs. The stock of NIKE, Inc. (NYSE:NKE) earned “Buy” rating by Goldman Sachs on Wednesday, June 29. The firm has “Overweight” rating by Morgan Stanley given on Wednesday, March 23. Canaccord Genuity maintained the shares of NKE in report on Wednesday, March 23 with “Hold” rating. The stock has “Hold” rating by J.P. Morgan on Friday, June 16.

Since September 14, 2017, it had 0 buys, and 6 sales for $23.60 million activity. On Friday, December 15 the insider PARKER MARK G sold $8.78 million. On Monday, December 11 the insider Matheson Monique S. sold $620,000. Shares for $855,206 were sold by RODGERS JOHNATHAN A on Thursday, September 14. The insider Slusher John F sold $4.75 million.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *